 TUSTIN, Calif., Aug. 30, 2022 GLOBE NEWSWIRE -- Avid Bioservices, Inc. NASDAQ:CDMO, a dedicated biologics contract development and manufacturing organization CDMO working to improve patient lives by providing high quality services to biotechnology and pharmaceutical companies, today announced that it will report financial results for the first quarter of fiscal year 2023 on September 6, 2022 after market close and will host a webcast at 1:30 PM Pacific Time 4:30 PM Eastern Time. Members of Avids senior management will discuss financial results for the first quarter and review recent corporate developments. 